世界の着床前遺伝子診断（PGD）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Preimplantation Genetics Diagnosis (PGD) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4767
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、着床前遺伝子診断（PGD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（性別選択、染色体異常、単一遺伝子障害、HLAタイピング、異数性、X連鎖性疾患、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・着床前遺伝子診断（PGD）の市場動向
・企業の競争状況、市場シェア
・着床前遺伝子診断（PGD）の種類別市場規模（性別選択、染色体異常、単一遺伝子障害、HLAタイピング、異数性、X連鎖性疾患、その他）
・着床前遺伝子診断（PGD）の用途別市場規模（病院、診療所、その他）
・着床前遺伝子診断（PGD）の北米市場規模2016-2027（アメリカ、カナダ）
・着床前遺伝子診断（PGD）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・着床前遺伝子診断（PGD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・着床前遺伝子診断（PGD）の中南米市場規模2016-2027（メキシコ、ブラジル）
・着床前遺伝子診断（PGD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott Laboratories、Natera, Inc、PerkinElmer、Illumina、F. Hoffmann-La Roche、Thermo Fisher Scientific、Laboratory Corporation of America Holdings、Agilent Technologies、Quest Diagnostics Incorporated、Cooper Surgical、Beijing Genomics Institute (BGI)、Genea Limited）
・結論

Market Analysis and Insights: Global Preimplantation Genetics Diagnosis (PGD) Market
The global Preimplantation Genetics Diagnosis (PGD) market size is projected to reach US$ 123.1 million by 2026, from US$ 96.4 million in 2019, at a CAGR of 3.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preimplantation Genetics Diagnosis (PGD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preimplantation Genetics Diagnosis (PGD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preimplantation Genetics Diagnosis (PGD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preimplantation Genetics Diagnosis (PGD) market.

Global Preimplantation Genetics Diagnosis (PGD) Scope and Market Size
Preimplantation Genetics Diagnosis (PGD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetics Diagnosis (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
Aneuploidy
X-Linked Diseases
Other

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Natera, Inc
PerkinElmer
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
Laboratory Corporation of America Holdings
Agilent Technologies
Quest Diagnostics Incorporated
Illumina

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gender Selection
1.2.3 Chromosomal Abnormalities
1.2.4 Single Gene Disorders
1.2.5 HLA Typing
1.2.6 Aneuploidy
1.2.7 X-Linked Diseases
1.2.8 Other
1.3 Market by Application
1.3.1 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Perspective (2016-2027)
2.2 Preimplantation Genetics Diagnosis (PGD) Growth Trends by Regions
2.2.1 Preimplantation Genetics Diagnosis (PGD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preimplantation Genetics Diagnosis (PGD) Historic Market Share by Regions (2016-2021)
2.2.3 Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Regions (2022-2027)
2.3 Preimplantation Genetics Diagnosis (PGD) Industry Dynamic
2.3.1 Preimplantation Genetics Diagnosis (PGD) Market Trends
2.3.2 Preimplantation Genetics Diagnosis (PGD) Market Drivers
2.3.3 Preimplantation Genetics Diagnosis (PGD) Market Challenges
2.3.4 Preimplantation Genetics Diagnosis (PGD) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue
3.1.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue (2016-2021)
3.1.2 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Players (2016-2021)
3.2 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetics Diagnosis (PGD) Revenue
3.4 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetics Diagnosis (PGD) Revenue in 2020
3.5 Preimplantation Genetics Diagnosis (PGD) Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
3.7 Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Type
4.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Type (2016-2021)
4.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2022-2027)

5 Preimplantation Genetics Diagnosis (PGD) Breakdown Data by Application
5.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Application (2016-2021)
5.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)
6.2 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type
6.2.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021)
6.2.2 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2022-2027)
6.2.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2027)
6.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application
6.3.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2021)
6.3.2 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2022-2027)
6.3.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2027)
6.4 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country
6.4.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2021)
6.4.2 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)
7.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type
7.2.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021)
7.2.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2022-2027)
7.2.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2027)
7.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application
7.3.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2021)
7.3.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2022-2027)
7.3.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2027)
7.4 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country
7.4.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2021)
7.4.2 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)
8.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type
8.2.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application
8.3.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region
8.4.1 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)
9.2 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type
9.2.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021)
9.2.2 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2022-2027)
9.2.3 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2027)
9.3 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application
9.3.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2021)
9.3.2 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2022-2027)
9.3.3 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2027)
9.4 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country
9.4.1 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2021)
9.4.2 Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size (2016-2027)
10.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type
10.2.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application
10.3.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country
10.4.1 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Introduction
11.1.4 Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Natera, Inc
11.2.1 Natera, Inc Company Details
11.2.2 Natera, Inc Business Overview
11.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Introduction
11.2.4 Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.2.5 Natera, Inc Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Details
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Introduction
11.3.4 PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.3.5 PerkinElmer Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Introduction
11.4.4 Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.4.5 Illumina Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Introduction
11.6.4 Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Laboratory Corporation of America Holdings
11.7.1 Laboratory Corporation of America Holdings Company Details
11.7.2 Laboratory Corporation of America Holdings Business Overview
11.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Introduction
11.7.4 Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.7.5 Laboratory Corporation of America Holdings Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Introduction
11.8.4 Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.8.5 Agilent Technologies Recent Development
11.9 Quest Diagnostics Incorporated
11.9.1 Quest Diagnostics Incorporated Company Details
11.9.2 Quest Diagnostics Incorporated Business Overview
11.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Introduction
11.9.4 Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.9.5 Quest Diagnostics Incorporated Recent Development
11.10 Cooper Surgical
11.10.1 Cooper Surgical Company Details
11.10.2 Cooper Surgical Business Overview
11.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Introduction
11.10.4 Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.10.5 Cooper Surgical Recent Development
11.11 Beijing Genomics Institute (BGI)
11.11.1 Beijing Genomics Institute (BGI) Company Details
11.11.2 Beijing Genomics Institute (BGI) Business Overview
11.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Introduction
11.11.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.11.5 Beijing Genomics Institute (BGI) Recent Development
11.12 Genea Limited
11.12.1 Genea Limited Company Details
11.12.2 Genea Limited Business Overview
11.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Introduction
11.12.4 Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
11.12.5 Genea Limited Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gender Selection
Table 3. Key Players of Chromosomal Abnormalities
Table 4. Key Players of Single Gene Disorders
Table 5. Key Players of HLA Typing
Table 6. Key Players of Aneuploidy
Table 7. Key Players of X-Linked Diseases
Table 8. Key Players of Other
Table 9. Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Regions (2016-2021)
Table 13. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Regions (2022-2027)
Table 15. Preimplantation Genetics Diagnosis (PGD) Market Trends
Table 16. Preimplantation Genetics Diagnosis (PGD) Market Drivers
Table 17. Preimplantation Genetics Diagnosis (PGD) Market Challenges
Table 18. Preimplantation Genetics Diagnosis (PGD) Market Restraints
Table 19. Global Preimplantation Genetics Diagnosis (PGD) Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Players (2016-2021)
Table 21. Global Top Preimplantation Genetics Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2020)
Table 22. Ranking of Global Top Preimplantation Genetics Diagnosis (PGD) Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Preimplantation Genetics Diagnosis (PGD) Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
Table 26. Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2016-2021)
Table 30. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Preimplantation Genetics Diagnosis (PGD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2016-2021)
Table 34. Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product
Table 69. Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 70. Abbott Laboratories Recent Development
Table 71. Natera, Inc Company Details
Table 72. Natera, Inc Business Overview
Table 73. Natera, Inc Preimplantation Genetics Diagnosis (PGD) Product
Table 74. Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 75. Natera, Inc Recent Development
Table 76. PerkinElmer Company Details
Table 77. PerkinElmer Business Overview
Table 78. PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product
Table 79. PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 80. PerkinElmer Recent Development
Table 81. Illumina Company Details
Table 82. Illumina Business Overview
Table 83. Illumina Preimplantation Genetics Diagnosis (PGD) Product
Table 84. Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 85. Illumina Recent Development
Table 86. F. Hoffmann-La Roche Company Details
Table 87. F. Hoffmann-La Roche Business Overview
Table 88. F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product
Table 89. F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 90. F. Hoffmann-La Roche Recent Development
Table 91. Thermo Fisher Scientific Company Details
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product
Table 94. Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 95. Thermo Fisher Scientific Recent Development
Table 96. Laboratory Corporation of America Holdings Company Details
Table 97. Laboratory Corporation of America Holdings Business Overview
Table 98. Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product
Table 99. Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 100. Laboratory Corporation of America Holdings Recent Development
Table 101. Agilent Technologies Company Details
Table 102. Agilent Technologies Business Overview
Table 103. Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 104. Agilent Technologies Recent Development
Table 105. Quest Diagnostics Incorporated Company Details
Table 106. Quest Diagnostics Incorporated Business Overview
Table 107. Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product
Table 108. Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 109. Quest Diagnostics Incorporated Recent Development
Table 110. Cooper Surgical Company Details
Table 111. Cooper Surgical Business Overview
Table 112. Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product
Table 113. Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 114. Cooper Surgical Recent Development
Table 115. Beijing Genomics Institute (BGI) Company Details
Table 116. Beijing Genomics Institute (BGI) Business Overview
Table 117. Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product
Table 118. Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 119. Beijing Genomics Institute (BGI) Recent Development
Table 120. Genea Limited Company Details
Table 121. Genea Limited Business Overview
Table 122. Genea Limited Preimplantation Genetics Diagnosis (PGD) Product
Table 123. Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 124. Genea Limited Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Type: 2020 VS 2027
Figure 2. Gender Selection Features
Figure 3. Chromosomal Abnormalities Features
Figure 4. Single Gene Disorders Features
Figure 5. HLA Typing Features
Figure 6. Aneuploidy Features
Figure 7. X-Linked Diseases Features
Figure 8. Other Features
Figure 9. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Other Case Studies
Figure 13. Preimplantation Genetics Diagnosis (PGD) Report Years Considered
Figure 14. Global Preimplantation Genetics Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Preimplantation Genetics Diagnosis (PGD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Regions: 2020 VS 2027
Figure 17. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Regions (2022-2027)
Figure 18. Global Preimplantation Genetics Diagnosis (PGD) Market Share by Players in 2020
Figure 19. Global Top Preimplantation Genetics Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetics Diagnosis (PGD) as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Preimplantation Genetics Diagnosis (PGD) Revenue in 2020
Figure 21. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2016-2021)
Figure 22. Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Type (2022-2027)
Figure 23. North America Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Preimplantation Genetics Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 25. North America Preimplantation Genetics Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 26. North America Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 27. United States Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Preimplantation Genetics Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 31. Europe Preimplantation Genetics Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 32. Europe Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 33. Germany Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Preimplantation Genetics Diagnosis (PGD) Market Share by Region (2016-2027)
Figure 43. China Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Preimplantation Genetics Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 51. Latin America Preimplantation Genetics Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 52. Latin America Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 53. Mexico Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Preimplantation Genetics Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 59. Turkey Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Preimplantation Genetics Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abbott Laboratories Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 63. Natera, Inc Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 64. PerkinElmer Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 65. Illumina Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 68. Laboratory Corporation of America Holdings Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 69. Agilent Technologies Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 70. Quest Diagnostics Incorporated Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 71. Cooper Surgical Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 72. Beijing Genomics Institute (BGI) Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 73. Genea Limited Revenue Growth Rate in Preimplantation Genetics Diagnosis (PGD) Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

以下、関連資料のご紹介

世界の着床前遺伝子診断（PGD）市場規模・現状・予測（2021年-2027年）

Global Preimplantation Genetics Diagnosis (PGD) Market Size, Status and Forecast 2021-2027
QYR2104Z4767 2021年4月 98Pages
QYResearch社発行の本調査資料では、着床前遺伝子診断（PGD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（性別選択、染色体異常、単一遺伝子障害、HLAタイピング、異数性、X連鎖性疾患、その他）、用途別市場規模（病院、診療所、その他）...

世界の着床前遺伝子診断（PGD）市場規模・現状・予測（2021年-2027年）

Global Pre-Implantation Genetic Diagnosis (PGD) Market Size, Status and Forecast 2021-2027
QYR2104Z4764 2021年4月 91Pages
QYResearch社発行の本調査資料では、着床前遺伝子診断（PGD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（染色体異常、X連鎖性疾患、凍結胚検査、異数性スクリーニング、HLA、その他）、用途別市場規模（幹細胞治療、IVF予後、遅発性遺...

世界の着床前遺伝子診断市場規模・現状・予測（2021年-2027年）

Global Preimplantation Genetic Diagnosis Market Size, Status and Forecast 2021-2027
QYR2104Z4765 2021年4月 90Pages
QYResearch社発行の本調査資料では、着床前遺伝子診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子診断、遺伝子スクリーニング）、用途別市場規模（不妊治療クリニック、研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の着床前遺伝子診断市場規模・現状・予測（2021年-2027年）

世界の着床前遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Preimplantation Genetic Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4766 2021年4月 128Pages
QYResearch社発行の本調査資料では、着床前遺伝子検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（着床前遺伝子スクリーニング、着床前遺伝子診断）、用途別市場規模（マタニティセンター＆不妊治療クリニック、病院、診断ラボ、サービスプロバイ...

世界の抗体薬物複合体（ADC）市場規模・現状・予測（2021年-2027年）

Global Antibody Drug Conjugates (ADCs) Market Size, Status and Forecast 2021-2027
QYR2104Z0372 2021年4月 97Pages
QYResearch社発行の本調査資料では、抗体薬物複合体（ADC）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シアトルジェネティクス技術、イミュノゲン技術、イミュノメディクス技術）、用途別市場規模（病院、クリニック、その他）、主要地域別市...

世界のポイントオブケア（POC）診断用ポリメラーゼ連鎖反応（PCR）市場規模・現状・予測（2021年-2027年）

Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z4693 2021年4月 97Pages
QYResearch社発行の本調査資料では、ポイントオブケア（POC）診断用ポリメラーゼ連鎖反応（PCR）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リアルタイムPCR、DNA/RNA精製）、用途別市場規模（病院、外来手術センター、診断セン...

世界のSTD診断市場規模・現状・予測（2021年-2027年）

Global STDs Diagnosis Market Size, Status and Forecast 2021-2027
QYR2104Z5433 2021年4月 97Pages
QYResearch社発行の本調査資料では、STD診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（淋病検査、人間パピローマウイルス（HPV）検査、クラミジア検査、軟性下疳検査、その他）、用途別市場規模（ポイントオブケア（POC）検査、検査室...

世界の肝炎検査診断市場規模・現状・予測（2021年-2027年）

Global Hepatitis Test Diagnosis Market Size, Status and Forecast 2021-2027
QYR2104Z2795 2021年4月 92Pages
QYResearch社発行の本調査資料では、肝炎検査診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B型肝炎（HBV）、C型肝炎（HCV）、その他肝炎疾患）、用途別市場規模（病院、ナーシングホーム、診断研究所、血液バンク、その他）、主要地域...

世界の次世代シーケンシング（NGS）市場規模・現状・予測（2021年-2027年）

Global Next Generation Sequencing (NGS) Market Size, Status and Forecast 2021-2027
QYR2104Z4131 2021年4月 127Pages
QYResearch社発行の本調査資料では、次世代シーケンシング（NGS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、プラットフォーム、サービス）、用途別市場規模（学術＆政府研究機関、製薬会社、バイオテクノロジー会社、病院＆クリニッ...

世界の着床前遺伝子診断（PGD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Preimplantation Genetics Diagnosis (PGD) Market The global Preimplantation Genetics Diagnosis (PGD) market size is projected to reach US$ 123.1 million by 2026, from US$ 96.4 million in 2019, at a CAGR of 3.5% during 2021-2026. With industry-standard accuracy in …
世界の着床前遺伝子診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Preimplantation Genetic Diagnosis Market The global Preimplantation Genetic Diagnosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
世界の着床前遺伝子診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Preimplantation Genetic Diagnosis Market The global Preimplantation Genetic Diagnosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
世界の着床前遺伝子検査市場規模・現状・予測（2021年-2027年） Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one or both genetic parents has a known genetic abnormality and testing is per…
世界の着床前遺伝子診断（PGD）市場規模・現状・予測（2021年-2027年） Pre-Implantation Genetic Diagnosis (PGD) is the genetic profiling of embryos prior to implantation (as a form of embryo profiling), and sometimes even of oocytes prior to fertilization. When used to screen for a specific genetic disease, PGD main advantage is that it avoids selective abortion, as th…